Open Access · CC BY-ND 4.0
Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study)
Pneumon · 2021
DOI: 10.18332/pne/144485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pneumon, 2021. Verfasst von Petros Bakakos und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bakakos, P., Papakosta, D., & Loukides, S. (2021). Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study). Pneumon. https://doi.org/10.18332/pne/144485
Vancouver
Bakakos P, Papakosta D, Loukides S. Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study). Pneumon. 2021. doi:10.18332/pne/144485
BibTeX
@article{Bakakos2021,
author = {Bakakos, Petros and Papakosta, Despoina and Loukides, Stylianos},
title = {Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: A real-world effectiveness study (The BOREAS Study)},
journal = {Pneumon},
year = {2021},
doi = {10.18332/pne/144485}
}
EUVIMED